Postoperative Nausea and VomitingNCT02355678
Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children
A study testing dexamethasone, Local anesthetic infiltration and General anesthesia in people with Postoperative Nausea and Vomiting, run by Makassed General Hospital at 1 site in Lebanon.
Trial summary
Tonsillectomy is one of the most frequent surgical operations performed in children [1-4]. It is usually associated with postoperative nausea and vomiting (PONV) with an incidence ranging from 23% to 73% [2]. Read more about this study
- Who is it for?
- Ages 2 to 13 yearsHealthy volunteers can take part
- Conditions the study is for
- Postoperative Nausea and Vomiting
- What is being tested?
- dexamethasone, Local anesthetic infiltration and General anesthesia
- Type of treatment
- Injection or infusion, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 129 participants
- Where
- 1 siteLebanon
- Study dates
- Jan 2015to Aug 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 13 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Patients scheduled for total or partial tonsillectomy with or without adenoidectomy
Who cannot join
- Patients who received antiemetics, steroids, antihistaminics, or psychoactive drugs within 24 hours before surgery.
- Patients who are suspected to have malignant neoplasm and signs of acute pharyngeal infection..
- Patients who have asthma, diabetes mellitus, bleeding problems, and allergy towards bupivacaine.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Dexamethasone Versus Local Infiltration Technique on Postoperative Nausea and Vomiting After Tonsillectomy in Children: A Randomized Double-blind Clinical Trial
Tonsillectomy is one of the most frequent surgical operations performed in children [1-4]. It is usually associated with postoperative nausea and vomiting (PONV) with an incidence ranging from 23% to 73% [2]. Dexamethasone has been shown to be effective in reducing PONV after tonsillectomy using standardized anesthetic technique [2, 5-7]. Previous studies utilizing a different technique, the pre-incision infiltration of local anesthesia, had shown to decrease post-tonsillectomy pain, reduce analgesic consumption and provide a rapid return to normal activity [8, 9]. Given the effectiveness of dexamethasone and the pre-incision infiltration anesthetic technique, it would be beneficial to compare the effect of each on PONV.
Read the detailed description
Objective The purpose of this study is to compare the effect of dexamethasone versus the pre-incision infiltration of local anesthesia in pediatric tonsillectomy procedures. The primary outcome parameter of the study is the incidence of early PONV in the post-anesthesia care unit (PACU) and late PONV on the floor and 5 days after discharge. The secondary outcome is postoperative pain.
Methods Definitions Nausea is difficult to assess in children since they are not able to verbalize their feelings. Retching, which is the unproductive effort to vomit (no expulsion of gastric content), is considered an indicator of nausea. Therefore, for the purpose of this study, PONV is defined as vomiting and/or retching. Early PONV is defined as vomiting and/or retching in the PACU. Late PONV is defined as vomiting and/or retching on the floor and 5 days after discharge.
Study design The study will be conducted prospectively, using a randomized double-blinded placebo-controlled design. Thus, neither the surgeon nor the anesthesiologist will be aware of the injected solution content and they will not be involved in data collection. The patients and the residents who will collect the data will also be unaware of the patient's assigned group.
Sampling
Patients scheduled for total or partial tonsillectomy with or without adenoidectomy starting from January 2015, whose ages range between 2 to 13 years will be included in the study.
Exclusion criteria consisted of patients who received antiemetics, steroids, antihistaminics, or psychoactive drugs within 24 hours before surgery. Patients who are suspected to have malignant neoplasm and signs of acute pharyngeal infection will be excluded from the study. Moreover, patients who have asthma, diabetes mellitus, bleeding problems, and allergy towards bupivacaine are excluded as well.
Upon meeting the eligibility criteria and signing the consent form, patients will be allocated randomly into two equal groups using the sealed envelope method. Both groups will have general anesthesia (GA) and endotracheal intubation. Then, one group will receive dexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration. The other group will receive pre-incision infiltration of 1.5 ml local anesthesia mixture in each tonsil and an equivalent volume of IV saline.
Anesthetic techniques General anesthesia General anesthesia will be induced by intravenous fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation facilitated by atracurium (0.5 mg kg-1). Anesthesia will be subsequently maintained with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%. The sevoflurane concentration will be adjusted with the intention of keeping the heart rate and blood pressure within 25% of pre-induction values [8, 9].
Modified infiltration technique The infiltration will be performed by the anesthetist using a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine 1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg ml-1 [8, 9].
Surgical techniques The tonsillectomy techniques were monopolar electrocautery or cold dissection. The degree of tonsillar enlargement was graded as follows: tonsils within tonsillar folds; tonsils just outside tonsillar folds; tonsils well outside tonsillar folds but not reaching uvula; tonsils reaching uvula or past uvula [3]. Towards the end of the surgery, gastric contents of all patients will be suctioned via an orogastric tube prior to extubation [10]. Patients were extubated when fully awake. Systemic IV paracetamol (15 mg/kg) was given to all patients.
Data collection Pre- and intraoperative data include: patient's demographics, surgical technique, amount of fentanyl consumed, heart rate, mean arterial pressure and oxygen concentration in addition to surgery duration. Data to be collected postoperatively in the PACU (by PACU nurse) and floor included: frequency of PONV, pain scores, antiemetic and analgesic consumption as well as patients' and surgeons' satisfaction. PONV will be assessed using questions adopted from Rhodes Index of Nausea, Vomiting and Retching (RINVR) but was modified for pediatrics [11, 12]. For children aged five years and older, pain will be measured using the Visual Analog Scale (VAS) with a score of 0 denoting no pain and 10 maximum possible pains. For children less than five years of age, the Wong-Baker faces pain scale will be used. Pain will be assessed at rest in addition to when opening the jaw, swallowing, eating soft and ordinary food. The parents will be told that they will be contacted through phone calls after their hospital discharge on a daily basis and will be asked about the pain intensity and analgesic consumption of their child. Patients will be followed-up by anesthesiology resident for five postoperative days.
Parents' satisfaction will be based on quality of communication and care provided by the anesthesiologists and nurses, in addition to parental opinion of the child's recollection and the overall experience. Surgeon satisfaction will be assessed using patients' comfort and number of phone calls made by parents.
Since the study is double-blind, neither the surgeon nor the anesthesiologist are aware of the injected solution content and were not involved in data collection. The patients and the trained nurses who collect the data are also unaware of the patient's assigned group.
Postoperative pain management For pain scores >5, 1-2 mg/kg of tramadol hydrochloride (Tramal drops, Laboratoire, Grunenthal, Aachen-Germany) would be given. If pain score is between 4 and 5, 15mg/kg intravenous propacetamol hydrochloride (Pro-Dafalgan Laboratoires, UPSA, Agen, France) will be provided. Paracetamol suppository 350 mg (Tylenol CILAG SA, Schaffhouse, Switzerland) will be administered for children with pain scores <4. Paracetamol suppository 350 mg is prescribed systematically two to four times a day as needed to all discharged children. If they experience pain with a score >5, tramadol hydrochloride will be prescribed.
Statistical Analysis Data will be statistically analyzed by chi-square test and t-test (two-tailed). P-value < 0.05 is considered significant. Results will be reported as mean and standard deviation (SD), or frequency and percentage as appropriate.
- Conditions
- Postoperative Nausea and Vomiting
- Being tested
- dexamethasone, Local anesthetic infiltration, General anesthesia, Tonsillectomy, gastric content suction
- Medical subject headings
- Postoperative Nausea and Vomiting
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
dexamethasoneDrug
IV 0.5 mg/kg
Local anesthetic infiltrationDrug
Using 25 G-3.5 cm curved needle
General anesthesiaDrug
Induction by intravenous fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation facilitated by atracurium (0.5 mg kg-1).
Maintenance with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%.
TonsillectomyProcedure or surgery
Mono-polar electrocautery or cold dissection
gastric content suctionProcedure or surgery
By orogastric tube
Tramadol hydrochlorideDrug
If Visual Analogue Scale was greater than 5
Propacetamol hydrochlorideDrug
If Visual Analogue Scale was between 4 and 5
Paracetamol SuppositoryDrug
If Visual Analogue Scale was less than 4
| Study group | Role | What they receive |
|---|---|---|
| IV Dex | Experimental | dexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration Receives: Drug: dexamethasone; Drug: General anesthesia; Procedure: Tonsillectomy; Procedure: gastric content suction; Drug: Tramadol hydrochloride; Drug: Propacetamol hydrochloride; Drug: Paracetamol Suppository |
| Infiltration | Experimental | The infiltration will be performed by the anesthetist using a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine 1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg ml-1 Receives: Drug: Local anesthetic infiltration; Drug: General anesthesia; Procedure: Tonsillectomy; Procedure: gastric content suction; Drug: Tramadol hydrochloride; Drug: Propacetamol hydrochloride; Drug: Paracetamol Suppository |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of postoperative nausea and vomiting
incidence of early PONV in the post-anesthesia care unit (PACU) and late PONV on the floor and 5 days after discharge
Measured: 5 postoperative days
Secondary outcomes (1)
Postoperative pain
Measured: 5 postoperative days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Feb 2015 (estimated)
- Study startJan 2015
- Primary completionAug 2015
- Study completionAug 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Postoperative Nausea and VomitingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Investigator
- Enrolment
- 129 participants (actual)
Sponsor and investigators
- Lead sponsor
- Makassed General Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zoher Naja, Makassed General Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02355678
- Sponsor's protocol ID
- 201212
- Status last verified
- Aug 2015
- First submitted
- 26 Jan 2015
- Last updated
- 21 Aug 2015
- Results posted
- No
- Data monitoring committee
- No
Publications
Naja Z, Kanawati S, Al Khatib R, Ziade F, Naja ZZ, Naja AS, Rajab M. The effect of IV dexamethasone versus local anesthetic infiltration technique in postoperative nausea and vomiting after tonsillectomy in children: A randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2017 Jan;92:21-26. doi: 10.1016/j.ijporl.2016.10.030. Epub 2016 Oct 28.
PubMed 28012528
Study at a glance
From the registry record, last updated by the sponsor on 21 Aug 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Dexamethasone Versus Local Infiltration Technique on Postoperative Nausea and Vomiting After Tonsillectomy in Children: A Randomized Double-blind Clinical Trial
- ClinicalTrials.gov ID
- NCT02355678
- Acronym / sponsor ID
- 201212
- Conditions
- Postoperative Nausea and Vomiting
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 129 participants (actual)
- Lead sponsor
- Makassed General HospitalUniversity, hospital or other
- Study start
- Jan 2015
- Primary completion
- Aug 2015 (actual)
- Study completion
- Aug 2015 (actual)
- First posted
- 4 Feb 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Tonsillectomy is one of the most frequent surgical operations performed in children [1-4]. It is usually associated with postoperative nausea and vomiting (PONV) with an incidence ranging from 23% to 73% [2]. Dexamethasone has been shown to be effective in reducing PONV after tonsillectomy using standardized anesthetic technique [2, 5-7]. Previous studies utilizing a different technique, the pre-incision infiltration of local anesthesia, had shown to decrease post-tonsillectomy pain, reduce analgesic consumption and provide a rapid return to normal activity [8, 9]. Given the effectiveness of dexamethasone and the pre-incision infiltration anesthetic technique, it would be beneficial to compare the effect of each on PONV.
Detailed description
Objective The purpose of this study is to compare the effect of dexamethasone versus the pre-incision infiltration of local anesthesia in pediatric tonsillectomy procedures. The primary outcome parameter of the study is the incidence of early PONV in the post-anesthesia care unit (PACU) and late PONV on the floor and 5 days after discharge. The secondary outcome is postoperative pain.
Methods Definitions Nausea is difficult to assess in children since they are not able to verbalize their feelings. Retching, which is the unproductive effort to vomit (no expulsion of gastric content), is considered an indicator of nausea. Therefore, for the purpose of this study, PONV is defined as vomiting and/or retching. Early PONV is defined as vomiting and/or retching in the PACU. Late PONV is defined as vomiting and/or retching on the floor and 5 days after discharge.
Study design The study will be conducted prospectively, using a randomized double-blinded placebo-controlled design. Thus, neither the surgeon nor the anesthesiologist will be aware of the injected solution content and they will not be involved in data collection. The patients and the residents who will collect the data will also be unaware of the patient's assigned group.
Sampling
Patients scheduled for total or partial tonsillectomy with or without adenoidectomy starting from January 2015, whose ages range between 2 to 13 years will be included in the study.
Exclusion criteria consisted of patients who received antiemetics, steroids, antihistaminics, or psychoactive drugs within 24 hours before surgery. Patients who are suspected to have malignant neoplasm and signs of acute pharyngeal infection will be excluded from the study. Moreover, patients who have asthma, diabetes mellitus, bleeding problems, and allergy towards bupivacaine are excluded as well.
Upon meeting the eligibility criteria and signing the consent form, patients will be allocated randomly into two equal groups using the sealed envelope method. Both groups will have general anesthesia (GA) and endotracheal intubation. Then, one group will receive dexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration. The other group will receive pre-incision infiltration of 1.5 ml local anesthesia mixture in each tonsil and an equivalent volume of IV saline.
Anesthetic techniques General anesthesia General anesthesia will be induced by intravenous fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation facilitated by atracurium (0.5 mg kg-1). Anesthesia will be subsequently maintained with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%. The sevoflurane concentration will be adjusted with the intention of keeping the heart rate and blood pressure within 25% of pre-induction values [8, 9].
Modified infiltration technique The infiltration will be performed by the anesthetist using a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine 1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg ml-1 [8, 9].
Surgical techniques The tonsillectomy techniques were monopolar electrocautery or cold dissection. The degree of tonsillar enlargement was graded as follows: tonsils within tonsillar folds; tonsils just outside tonsillar folds; tonsils well outside tonsillar folds but not reaching uvula; tonsils reaching uvula or past uvula [3]. Towards the end of the surgery, gastric contents of all patients will be suctioned via an orogastric tube prior to extubation [10]. Patients were extubated when fully awake. Systemic IV paracetamol (15 mg/kg) was given to all patients.
Data collection Pre- and intraoperative data include: patient's demographics, surgical technique, amount of fentanyl consumed, heart rate, mean arterial pressure and oxygen concentration in addition to surgery duration. Data to be collected postoperatively in the PACU (by PACU nurse) and floor included: frequency of PONV, pain scores, antiemetic and analgesic consumption as well as patients' and surgeons' satisfaction. PONV will be assessed using questions adopted from Rhodes Index of Nausea, Vomiting and Retching (RINVR) but was modified for pediatrics [11, 12]. For children aged five years and older, pain will be measured using the Visual Analog Scale (VAS) with a score of 0 denoting no pain and 10 maximum possible pains. For children less than five years of age, the Wong-Baker faces pain scale will be used. Pain will be assessed at rest in addition to when opening the jaw, swallowing, eating soft and ordinary food. The parents will be told that they will be contacted through phone calls after their hospital discharge on a daily basis and will be asked about the pain intensity and analgesic consumption of their child. Patients will be followed-up by anesthesiology resident for five postoperative days.
Parents' satisfaction will be based on quality of communication and care provided by the anesthesiologists and nurses, in addition to parental opinion of the child's recollection and the overall experience. Surgeon satisfaction will be assessed using patients' comfort and number of phone calls made by parents.
Since the study is double-blind, neither the surgeon nor the anesthesiologist are aware of the injected solution content and were not involved in data collection. The patients and the trained nurses who collect the data are also unaware of the patient's assigned group.
Postoperative pain management For pain scores >5, 1-2 mg/kg of tramadol hydrochloride (Tramal drops, Laboratoire, Grunenthal, Aachen-Germany) would be given. If pain score is between 4 and 5, 15mg/kg intravenous propacetamol hydrochloride (Pro-Dafalgan Laboratoires, UPSA, Agen, France) will be provided. Paracetamol suppository 350 mg (Tylenol CILAG SA, Schaffhouse, Switzerland) will be administered for children with pain scores <4. Paracetamol suppository 350 mg is prescribed systematically two to four times a day as needed to all discharged children. If they experience pain with a score >5, tramadol hydrochloride will be prescribed.
Statistical Analysis Data will be statistically analyzed by chi-square test and t-test (two-tailed). P-value < 0.05 is considered significant. Results will be reported as mean and standard deviation (SD), or frequency and percentage as appropriate.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| IV Dex | Experimental | Drug: dexamethasone, Drug: General anesthesia, Procedure: Tonsillectomy, Procedure: gastric content suction, Drug: Tramadol hydrochloride, Drug: Propacetamol hydrochloride, Drug: Paracetamol Suppositorydexamethasone 0.5 mg/kg IV with placebo pre-incision infiltration |
| Infiltration | Experimental | Drug: Local anesthetic infiltration, Drug: General anesthesia, Procedure: Tonsillectomy, Procedure: gastric content suction, Drug: Tramadol hydrochloride, Drug: Propacetamol hydrochloride, Drug: Paracetamol SuppositoryThe infiltration will be performed by the anesthetist using a 25G- 3.5cm curved needle. A total of 1.5 ml of local anesthetic mixture will be used for each tonsil. The mixture will contain: 3 ml lidocaine 2%, 3 ml lidocaine 2% with epinephrine 1/200 000, 3 ml of bupivacaine 0.5%, 0.5 ml fentanyl 50 µg ml-1, and 0.3 ml clonidine 150 µg ml-1 |
Who may qualify
- Ages
- 2 to 13 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- Patients scheduled for total or partial tonsillectomy with or without adenoidectomy
Key exclusion criteria (3 listed)
- Patients who received antiemetics, steroids, antihistaminics, or psychoactive drugs within 24 hours before surgery.
- Patients who are suspected to have malignant neoplasm and signs of acute pharyngeal infection..
- Patients who have asthma, diabetes mellitus, bleeding problems, and allergy towards bupivacaine.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| dexamethasoneIV 0.5 mg/kg | Drug | IV Dex |
| Local anesthetic infiltrationUsing 25 G-3.5 cm curved needle | Drug | Infiltration |
| General anesthesiaInduction by intravenous fentanyl (1.5 µg kg-1) and propofol (2.5 mg kg-1) followed by endotracheal intubation facilitated by atracurium (0.5 mg kg-1). Maintenance with sevoflurane 1-3%, fentanyl (1-2 µg kg-1), nitrous oxide 70% and oxygen 30%. | Drug | IV Dex, Infiltration |
| TonsillectomyMono-polar electrocautery or cold dissection | Procedure or surgery | IV Dex, Infiltration |
| gastric content suctionBy orogastric tube | Procedure or surgery | IV Dex, Infiltration |
| Tramadol hydrochlorideIf Visual Analogue Scale was greater than 5 | Drug | IV Dex, Infiltration |
| Propacetamol hydrochlorideIf Visual Analogue Scale was between 4 and 5 | Drug | IV Dex, Infiltration |
| Paracetamol SuppositoryIf Visual Analogue Scale was less than 4 | Drug | IV Dex, Infiltration |
Primary outcome
Incidence of postoperative nausea and vomiting
Time frame: 5 postoperative days
incidence of early PONV in the post-anesthesia care unit (PACU) and late PONV on the floor and 5 days after discharge
1 secondary outcome
Postoperative pain
Time frame: 5 postoperative days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Aug 2015.
- Derived from this study: PubMed 28012528Naja Z, Kanawati S, Al Khatib R, Ziade F, Naja ZZ, Naja AS, Rajab M. The effect of IV dexamethasone versus local anesthetic infiltration technique in postoperative nausea and vomiting after tonsillectomy in children: A randomized double-blind clinical trial. Int J Pediatr Otorhinolaryngol. 2017 Jan;92:21-26. doi: 10.1016/j.ijporl.2016.10.030. Epub 2016 Oct 28.
Related trials for Postoperative Nausea and Vomiting
Not yet recruitingObservational study
Preoperative Gastric Volume and PONV in Pediatric Appendectomy Cases
Postoperative Nausea and Vomiting
Not yet recruiting
Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery
PONV
Not yet recruiting
Binaural Beats and Postoperative Nausea and Vomiting in Laparoscopic Cholecystectomy
Laparoscopic Cholecystectomy
Active, not recruiting
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
Postoperative Nausea, Postoperative Vomiting
Not yet recruitingPhase 4
Effect of Ketamine-Propofol Total Intravenous Anesthesia Versus Sevoflurane-Based Anesthesia on Postoperative Vomiting in Children Undergoing Strabismus Surgery
Postoperative Vomiting, Postoperative Nausea and Vomiting
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing dexamethasone, Local anesthetic infiltration and General anesthesia in people with Postoperative Nausea and Vomiting, run by Makassed General Hospital at 1 site in Lebanon.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Aug 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of postoperative nausea and vomiting (time frame: 5 postoperative days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02355678, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2015.